DVA

#704
DaVita Inc. Common Stock
194.4 1 USD
-1.38%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
193.96
195.97
년간 변동
101.00
202.58
일일 변동
-1.38%
월간 변동
+28.82%
6달 변화
+63.00%
년간 변동율
+43.39%
이전 종가
197.1 4
Open
195.9 7
저가
193.9 6
High
195.9 7
양
385
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 12.48 B
  • Employee 78 K
  • Founded 1992
  • CEO Javier J. Rodriguez
  • Website www.davita.com
  • Headquarter Delaware, United States
  • FIGI BBG000MQ1SN9
  • Industry 의료 기관
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
14.35
주가매출액비율
0.82

DaVita Inc. Common Stock

DaVita Inc., incorporated in Delaware and headquartered in Denver, provides kidney dialysis services through a network of 2,657 outpatient centers in the United States, serving 200,500 patients, and 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation. In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the Fortune 500.

뉴스